Teresa Zyczynski

1.3k total citations
44 papers, 1.0k citations indexed

About

Teresa Zyczynski is a scholar working on Hematology, Rheumatology and Genetics. According to data from OpenAlex, Teresa Zyczynski has authored 44 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Hematology, 11 papers in Rheumatology and 9 papers in Genetics. Recurrent topics in Teresa Zyczynski's work include Chronic Myeloid Leukemia Treatments (10 papers), Chronic Lymphocytic Leukemia Research (9 papers) and Multiple Myeloma Research and Treatments (9 papers). Teresa Zyczynski is often cited by papers focused on Chronic Myeloid Leukemia Treatments (10 papers), Chronic Lymphocytic Leukemia Research (9 papers) and Multiple Myeloma Research and Treatments (9 papers). Teresa Zyczynski collaborates with scholars based in United States, Germany and United Kingdom. Teresa Zyczynski's co-authors include Karin S. Coyne, Louis S. Matza, Mary Kay Margolis, Victor Elinoff, Richard G. Roberts, Zhanna Jumadilova, James A. Tumlin, Bela Bapat, Sujha Subramanian and Jessica Brewster‐Jordan and has published in prestigious journals such as Journal of Clinical Oncology, Blood and The Journal of Urology.

In The Last Decade

Teresa Zyczynski

42 papers receiving 966 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Teresa Zyczynski United States 15 456 399 302 145 144 44 1.0k
Narelle S Willis Australia 21 137 0.3× 73 0.2× 191 0.6× 38 0.3× 72 0.5× 31 1.5k
Kristen Migliaccio–Walle United States 16 82 0.2× 86 0.2× 153 0.5× 186 1.3× 55 0.4× 48 856
Guillaume Ducarme France 21 180 0.4× 50 0.1× 100 0.3× 96 0.7× 56 0.4× 144 2.0k
Aleksandra Żurowska Poland 21 64 0.1× 176 0.4× 68 0.2× 167 1.2× 39 0.3× 79 1.5k
Teppei Okamoto Japan 16 107 0.2× 116 0.3× 67 0.2× 36 0.2× 36 0.3× 93 805
Dionysios Mitropoulos Greece 16 232 0.5× 434 1.1× 90 0.3× 83 0.6× 26 0.2× 61 1.5k
Luke T. Lavallée Canada 20 140 0.3× 181 0.5× 93 0.3× 303 2.1× 31 0.2× 134 1.7k
Marie‐Alice Macher France 21 57 0.1× 145 0.4× 61 0.2× 37 0.3× 161 1.1× 59 1.4k
Aytül Noyan Türkiye 16 34 0.1× 103 0.3× 63 0.2× 90 0.6× 94 0.7× 70 825
Fabrizio Gallo Italy 15 273 0.6× 212 0.5× 64 0.2× 21 0.1× 12 0.1× 55 801

Countries citing papers authored by Teresa Zyczynski

Since Specialization
Citations

This map shows the geographic impact of Teresa Zyczynski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Teresa Zyczynski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Teresa Zyczynski more than expected).

Fields of papers citing papers by Teresa Zyczynski

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Teresa Zyczynski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Teresa Zyczynski. The network helps show where Teresa Zyczynski may publish in the future.

Co-authorship network of co-authors of Teresa Zyczynski

This figure shows the co-authorship network connecting the top 25 collaborators of Teresa Zyczynski. A scholar is included among the top collaborators of Teresa Zyczynski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Teresa Zyczynski. Teresa Zyczynski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zyczynski, Teresa, et al.. (2022). HSR22-184: The Association of the Social Vulnerability Index to Timely Treatment of Metastatic Cancers Among Insured Adult Patients in the US. Journal of the National Comprehensive Cancer Network. 20(3.5). HSR22–184. 3 indexed citations
2.
Kamal, Mona, Xin Shelley Wang, Qiuling Shi, et al.. (2020). Symptom burden and its functional impact in patients with “symptomatic” relapsed or refractory multiple myeloma. Supportive Care in Cancer. 29(1). 467–475. 19 indexed citations
3.
Hehlmann, Rüdiger, Jörge E. Cortes, Teresa Zyczynski, et al.. (2018). Tyrosine kinase inhibitor interruptions, discontinuations and switching in patients with chronic‐phase chronic myeloid leukemia in routine clinical practice: SIMPLICITY. American Journal of Hematology. 94(1). 46–54. 33 indexed citations
4.
Kim, Dong‐Wook, Susanne Saußele, Loretta A. Williams, et al.. (2018). Outcomes of switching to dasatinib after imatinib-related low-grade adverse events in patients with chronic myeloid leukemia in chronic phase: the DASPERSE study. Annals of Hematology. 97(8). 1357–1367. 12 indexed citations
5.
Vij, Ravi, Clara Chen, Brian G.M. Durie, et al.. (2017). Treatment Patterns and Associated Outcomes in Patients with Relapsed or Refractory Multiple Myeloma in the US and Non-US Countries: Findings from Preamble. Blood. 130. 3123–3123. 2 indexed citations
6.
7.
Durie, Brian G.M., David J. Kuter, Catherine Davis, et al.. (2016). An Ongoing, Observational Cohort Study in Multiple Myeloma (PREAMBLE): Preliminary Efficacy Analyses in Patients with 1 Line of Prior Therapy. Blood. 128(22). 2403–2403.
8.
Goldschmidt, Hartmut, Ravi Vij, David J. Kuter, et al.. (2016). Health care resource utilization (HCRU) in relapsed/refractory multiple myeloma (RRMM): Results from PREAMBLE.. Journal of Clinical Oncology. 34(15_suppl). 6621–6621. 2 indexed citations
9.
10.
Paquette, Ronald, Bengt Simonsson, Elisabetta Abruzzese, et al.. (2015). CARDIOVASCULAR (CV)-RELATED HOSPITALIZATION IN PATIENTS WITH CHRONIC-PHASE CHRONIC MYELOID LEUKEMIA (CP-CML) IN SIMPLICITY, A PROSPECTIVE OBSERVATIONAL STUDY. Haematologica. 100. 437–437. 2 indexed citations
11.
Goldberg, Stuart L., Jörge E. Cortes, Carlo Gambacorti‐Passerini, et al.. (2014). Predictors of performing response monitoring in patients with chronic-phase chronic myeloid leukemia (CP-CML) in a prospective observational study (SIMPLICITY).. Journal of Clinical Oncology. 32(30_suppl). 116–116. 4 indexed citations
12.
Zyczynski, Teresa, et al.. (2013). Treatment Patterns After Castration Resistant Prostate Cancer (Crpc) Diagnosis: A European Physician Survey. Value in Health. 16(3). A1–A1. 2 indexed citations
13.
Cortes, Jörge E., Rüdiger Hehlmann, Carlo Gambacorti‐Passerini, et al.. (2013). Baseline Characteristics Of Patients With Chronic Myeloid Leukemia In a Prospective Observational Study (SIMPLICITY). Blood. 122(21). 4026–4026. 4 indexed citations
14.
Bharmal, Murtuza, et al.. (2008). Resource utilisation, charges and mortality following hospital inpatient admission for congestive heart failure among the elderly in the US. Journal of Medical Economics. 11(3). 397–414. 11 indexed citations
15.
Coyne, Karin S., et al.. (2005). 6: Relevance of 3 Sexual Quality of Life Questionnaires to Women with Overactive Bladder and Urinary Incontinence. The Journal of Urology. 173(4S). 2–2. 2 indexed citations
16.
17.
Zyczynski, Teresa, et al.. (2001). Effects of candesartan cilexetil on health-related quality of life in black patients with systemic hypertension in the ABC Trial.. PubMed. 2(6). 400–6. 5 indexed citations
18.
Kloner, Robert A., Myron H. Weinberger, James L. Pool, et al.. (2001). Comparative effects of candesartan cilexetil and amlodipine in patients with mild systemic hypertension. The American Journal of Cardiology. 87(6). 727–731. 55 indexed citations
19.
Zyczynski, Teresa & Karin S. Coyne. (2000). Hypertension and current issues in compliance and patient outcomes. Current Hypertension Reports. 2(6). 510–514. 35 indexed citations
20.
Leidy, Nancy Kline, Anne M. Rentz, & Teresa Zyczynski. (1999). Evaluating Health-Related Quality-of-Life Outcomes in Patients with Congestive Heart Failure. PharmacoEconomics. 15(1). 19–46. 50 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Narelle S Willis Breakdown of academic impact, for papers by Kristen Migliaccio–Walle Breakdown of academic impact, for papers by Guillaume Ducarme Breakdown of academic impact, for papers by Aleksandra Żurowska Breakdown of academic impact, for papers by Teppei Okamoto Breakdown of academic impact, for papers by Dionysios Mitropoulos Breakdown of academic impact, for papers by Luke T. Lavallée Breakdown of academic impact, for papers by Marie‐Alice Macher Breakdown of academic impact, for papers by Aytül Noyan Breakdown of academic impact, for papers by Fabrizio Gallo
Rankless by CCL
2026